Effects of Antrodia Cinnamomea on Spinocerebellar Ataxia Symptoms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of Antrodia cinnamomea products on clinical symptoms in patients with spinocerebellar ataxia. It employs a randomized, double-blind, placebo-controlled crossover design to ensure robust results. The study aims to provide insights into potential advancements in treating neurodegenerative diseases. Participants will receive either the treatment or a placebo in a controlled manner to assess the efficacy of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adults aged 30 to 70 years, whose native language is Chinese.
2. Patients diagnosed with Spinocerebellar Ataxia.
3. Subjects with a score below 30 on the Scale for the Assessment and Rating of Ataxia (SARA scale).
4. Individuals who can read and write in Chinese and communicate in Chinese.
5. Agree to participate in the study.

Exclusion Criteria:

1. Patients with severe systemic diseases, such as heart or respiratory failure, liver or kidney failure, severe brain injury, prolonged bed rest, or incurable malignancies.
2. Pregnant women and breastfeeding mothers.
3. Patients who have taken Antrodia cinnamomea products within the last 6 months prior to the trial.
4. Patients with other factors that prevent them from continuing to participate in this study.

Where it's running

• National Taiwan University Cancer Center
  Taipei, Taiwan Recruiting

Study contacts

• Principal investigator: MingChe Kuo — National Taiwan University
• Study coordinator: Yu Hsuan Chang
• Email: hsuan1989@alps.com.tw
• Phone: +886955551989

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Eye problems in dominant spinocerebellar ataxias

  This project tests whether adults with SCA1, SCA2, SCA3, or SCA27B have retinal or optic nerve changes by doing neurological and eye exams.

  Recruiting University Hospital, Montpellier · Montpellier, Hérault · NCT07019558

• Registry for Spinocerebellar Ataxias in Hong Kong

  This study is creating a registry for spinocerebellar ataxias in Hong Kong to help understand the condition better by collecting information from people diagnosed with it and their family members.

  Recruiting Chinese University of Hong Kong · Hong Kong, Shatin · NCT03336008

• Observing the natural progression of spinocerebellar ataxia

  This study looks at how different types of spinocerebellar ataxia progress over time to help understand the disease better and improve care for those affected.

  Recruiting Ataxia Study Group · Innsbruck and 15 other locations · NCT02440763

• Interposed Nucleus aDBS for Ataxia in SCA6

  A small, single-center study will try a cerebellar adaptive deep brain stimulation approach to help adults with Spinocerebellar Ataxia type 6.

  Recruiting University of Florida · Gainesville, Florida · NCT07325487

• Adaptive deep brain stimulation in the cerebellum for spinocerebellar ataxia type 6

  This will see if an implanted adaptive deep brain stimulator placed in the cerebellum can reduce movement and balance problems in adults with SCA6 who still have symptoms.

  Recruiting University of California, San Francisco · San Francisco, California and 1 other locations · NCT07288437

• Registry for patients with rare diseases

  This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.

  Recruiting Sanford Health · Sioux Falls, South Dakota · NCT01793168

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.